Recovery Over Time and Prognostic Factors in Treated Patients with Post-Infectious Olfactory Dysfunction: A Retrospective Study

被引:13
|
作者
Ogawa, Takao [1 ]
Nakamura, Keigo [1 ]
Yamamoto, Sayuri [1 ]
Tojima, Ichiro [1 ]
Shimizu, Takeshi [1 ]
机构
[1] Shiga Univ Med Sci, Dept Otorhinolaryngol, Otsu, Shiga 5202192, Japan
关键词
post-infectious; olfactory dysfunction; recovery; prognostic factor; Toki-shakuyaku-san; zinc; NERVE GROWTH-FACTOR; DOUBLE-BLIND; VITAMIN-A; FOLLOW-UP; BIOPSIES;
D O I
10.1177/0003489420922563
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objectives: The aims of the present study were to clarify the time-course of olfactory recovery and the prognostic factors in PIOD patients treated with Toki-shakuyaku-san (TSS). Methods: A retrospective cohort study of patients with PIOD was conducted by reviewing patients' medical records. This study included patients who received TSS or a combination of TSS and zinc sulfate. Olfactory function was examined by T&T olfactometer at each 3-monthly follow-up visit. Patients with normal and mild olfactory dysfunction were excluded. Gender, age, treatment, duration of disease until the first visit and olfactory function scores of the T&T olfactometer at the first visit were analyzed as candidate clinical predictors of recovery. Results: A total of 82 PIOD patients with ages ranging from 16 to 79 years were included. The mean duration of follow-up was 14.5 months (range 3-45 months). The number of patients with olfactory recovery increased for 24 months and the cumulative recovery rate was 77.3%. In about 60% of patients, olfactory recovery occurred within 6 months. Multivariate analysis showed that younger age (<65 years) and residual olfactory function were significantly associated with good olfactory recovery. Conclusions: We revealed recovery rates over time in patients with PIOD. The recovery of olfactory function often occurred during the early period (<= 6 months). However, the number of patients with olfactory recovery increased for a long-term of 24 months after the first visit. Residual olfactory function and younger age were prognostic factors exactly. TSS may be a useful therapeutic agent for patients with PIOD. We believe that these results provide important information that is useful for counseling patients with PIOD.
引用
收藏
页码:977 / 982
页数:6
相关论文
共 50 条
  • [21] Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients
    Lechien, J. R.
    Chiesa-Estomba, C. M.
    Beckers, E.
    Mustin, V
    Ducarme, M.
    Journe, F.
    Marchant, A.
    Jouffe, L.
    Barillari, M. R.
    Cammaroto, G.
    Circiu, M. P.
    Hans, S.
    Saussez, S.
    JOURNAL OF INTERNAL MEDICINE, 2021, 290 (02) : 451 - 461
  • [22] A retrospective study on the prognostic factors and success, survival, and failure outcomes of treated endodontic-periodontal lesions
    Wong, Ingar
    Ton, An
    Cassidy, Amiel J.
    Fozzard, Nicolette
    Sharma, Lavanya Ajay
    Love, Robert M.
    Sharma, Ajay
    CLINICAL AND EXPERIMENTAL DENTAL RESEARCH, 2024, 10 (01):
  • [23] Prevalence and 24-month recovery of olfactory dysfunction in COVID-19 patients: A multicentre prospective study
    Lechien, Jerome R.
    Vaira, Luigi A.
    Saussez, Sven
    JOURNAL OF INTERNAL MEDICINE, 2023, 293 (01) : 82 - 90
  • [24] Clinical and therapeutic features and prognostic factors of metastatic colorectal cancer over age 80: a retrospective study
    Hisada, Hiroyuki
    Takahashi, Yu
    Kubota, Manabu
    Shimura, Haruhisa
    Itobayashi, Ei
    Shimura, Kenji
    Nakamura, Akira
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [25] Clinical and therapeutic features and prognostic factors of metastatic colorectal cancer over age 80: a retrospective study
    Hiroyuki Hisada
    Yu Takahashi
    Manabu Kubota
    Haruhisa Shimura
    Ei Itobayashi
    Kenji Shimura
    Akira Nakamura
    BMC Gastroenterology, 21
  • [26] Treatment Outcome and Prognostic Factors of Korean Patients with Chronic Lymphocytic Leukemia: Multicenter Retrospective Study
    Choi, Yunsuk
    Lee, Jung-Hee
    Jung, Chul Won
    Kim, Jin Seok
    Kim, Inho
    Park, Silvia
    Cheong, June-Won
    Park, Seonyang
    Kim, Sung-Yong
    Lee, Mark Hong
    BLOOD, 2014, 124 (21)
  • [27] Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients
    Seong, J
    Park, HC
    Han, KH
    Chon, CY
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (02): : 329 - 336
  • [28] Prognostic factors in patients with septic disseminated intravascular coagulation treated with thrombomodulin: the effect of reduced thrombomodulin dose; a single-center, retrospective, observational study
    Nishita, Yoshihiro
    Taga, Masatoshi
    Sakurai, Masaru
    Iinuma, Yoshitsugu
    Masauji, Togen
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2022, 8 (01)
  • [29] The prevalence of olfactory dysfunction and its associated factors in patients with COVID-19 infection: A Hospital-based study
    Hasan, Md Mehedi
    Tamanna, Naima Ahmed
    Jamal, Mohammad Nasimul
    Jamil, Abu Naser Md
    Uddin, Md Jamal
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2023, 22 (01): : 195 - 204
  • [30] Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection
    Lin, Emily Pei-Ying
    Hsu, Chih-Yuan
    Mishra, Sanjay
    Griffiths, Elizabeth A.
    Segal, Brahm H.
    Hwang, Clara
    Singh, Sunny R. K.
    Balanchivadze, Nino
    Jani, Chinmay
    Mariano, Melissa G.
    Bhatt, Padmanabh S.
    Vieira, Kendra
    Yu, Peter Paul
    Oligino, Eric J.
    Wise-Draper, Trisha
    Ferrara, Elizabeth K.
    McKay, Rana R.
    Nonato, Taylor K.
    Labaki, Chris
    Saad, Eddy
    Saliby, Renee-Maria
    Morgans, Alicia K.
    Nohria, Anju
    Puc, Matthew
    Accordino, Melissa K.
    Bodin, Brianne E.
    Nanchal, Rahul
    Singh, Harpreet
    Berg, Stephanie
    Mavromatis, Blanche
    McManus, Hannah D.
    Halabi, Susan
    Choueiri, Toni K.
    Warner, Jeremy L.
    Shyr, Yu
    LANCET REGIONAL HEALTH-AMERICAS, 2025, 44